FI54311C - PROCEDURE FOR THE FRAMSTATION OF AV PYRIMIDINOBENSO-OXAZEPINER -TIAZEPINER -DIAZEPINER OCH -AZEPINER WITH INVERKAN PAO CENTRALNERVSYSTEMET - Google Patents

PROCEDURE FOR THE FRAMSTATION OF AV PYRIMIDINOBENSO-OXAZEPINER -TIAZEPINER -DIAZEPINER OCH -AZEPINER WITH INVERKAN PAO CENTRALNERVSYSTEMET

Info

Publication number
FI54311C
FI54311C FI2963/73A FI296373A FI54311C FI 54311 C FI54311 C FI 54311C FI 2963/73 A FI2963/73 A FI 2963/73A FI 296373 A FI296373 A FI 296373A FI 54311 C FI54311 C FI 54311C
Authority
FI
Finland
Prior art keywords
tiazepiner
pyrimidinobenso
oxazepiner
diazepiner
centralnervsystemet
Prior art date
Application number
FI2963/73A
Other languages
Finnish (fi)
Other versions
FI54311B (en
Inventor
Willem Jacob Van Der Burg
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI54311B publication Critical patent/FI54311B/en
Application granted granted Critical
Publication of FI54311C publication Critical patent/FI54311C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/554Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI2963/73A 1972-09-23 1973-09-21 PROCEDURE FOR THE FRAMSTATION OF AV PYRIMIDINOBENSO-OXAZEPINER -TIAZEPINER -DIAZEPINER OCH -AZEPINER WITH INVERKAN PAO CENTRALNERVSYSTEMET FI54311C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NLAANVRAGE7212915,A NL176458C (en) 1972-09-23 1972-09-23 PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING ACTIVE SUBSTANCES SUITABLE.

Publications (2)

Publication Number Publication Date
FI54311B FI54311B (en) 1978-07-31
FI54311C true FI54311C (en) 1978-11-10

Family

ID=19816997

Family Applications (1)

Application Number Title Priority Date Filing Date
FI2963/73A FI54311C (en) 1972-09-23 1973-09-21 PROCEDURE FOR THE FRAMSTATION OF AV PYRIMIDINOBENSO-OXAZEPINER -TIAZEPINER -DIAZEPINER OCH -AZEPINER WITH INVERKAN PAO CENTRALNERVSYSTEMET

Country Status (18)

Country Link
US (1) US3892695A (en)
JP (1) JPS5912678B2 (en)
AR (1) AR203090A1 (en)
AU (1) AU472312B2 (en)
BE (1) BE805178A (en)
CA (1) CA1019733A (en)
CH (1) CH592094A5 (en)
DE (1) DE2347727C2 (en)
DK (1) DK140668B (en)
ES (1) ES418996A1 (en)
FI (1) FI54311C (en)
FR (1) FR2199996B1 (en)
GB (1) GB1445765A (en)
HU (1) HU167206B (en)
IE (1) IE38221B1 (en)
NL (1) NL176458C (en)
SE (1) SE407686B (en)
ZA (1) ZA737131B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217452A (en) * 1974-02-09 1980-08-12 Akzona Incorporated Synthesis for the preparation of tetracyclic compounds
NL179906C (en) * 1974-02-09 1986-12-01 Akzo Nv PROCESS FOR PREPARING 1,2,3,4,10,14B-HEXAHYDRODIBENZO (C, F) PYRAZINO (1,2-A) AZEPINE DERIVATIVES.
NL7414038A (en) * 1974-10-28 1976-05-03 Akzo Nv NEW TETRACYCLIC PYRROLIDINO DERIVATIVES.
GB1472382A (en) * 1975-01-16 1977-05-04 Wyeth John & Brother Ltd Dibenzopyrimidoazepines
NL7610942A (en) * 1976-10-02 1978-04-04 Akzo Nv PROCESS FOR PREPARING 1,4-DIAZEPINE DERIVATIVES.
NL7809726A (en) * 1978-09-26 1980-03-28 Akzo Nv NEW TETRACYCLIC CONNECTIONS.
HU195491B (en) * 1985-12-20 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for production of optically active 2-chlor-12-/3-/dimethil-amin/-2-methil-prophil/-12h-dibenzol /d,g/ /1,3,6/-diaxazocine and medical compositions containing such compounds
CH678623A5 (en) * 1989-05-17 1991-10-15 Sochinaz Societe Chimique De V Prepn. of di:benzo pyrazino azepine(s)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154511B (en) * 1967-07-07 1977-09-15 Organon Nv PROCESS FOR PREPARING PIPERAZINE DERIVATIVES, PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION CONTAINING SUCH A COMPOUND AND MOLDS PREPARED ACCORDING TO THIS PROCEDURE.
US3470181A (en) * 1967-10-23 1969-09-30 American Home Prod Fused 2-pyrimidinepropionic acid compounds,related compounds,and the process for their preparation

Also Published As

Publication number Publication date
AU472312B2 (en) 1976-05-20
AU6019773A (en) 1975-03-13
CH592094A5 (en) 1977-10-14
HU167206B (en) 1975-09-27
FR2199996B1 (en) 1977-09-09
CA1019733A (en) 1977-10-25
NL7212915A (en) 1974-03-26
FR2199996A1 (en) 1974-04-19
AR203090A1 (en) 1975-08-14
SE407686B (en) 1979-04-09
IE38221B1 (en) 1978-01-18
FI54311B (en) 1978-07-31
GB1445765A (en) 1976-08-11
DK140668B (en) 1979-10-22
JPS5912678B2 (en) 1984-03-24
NL176458C (en) 1985-04-16
ES418996A1 (en) 1976-07-01
IE38221L (en) 1974-03-23
DK140668C (en) 1980-03-24
US3892695A (en) 1975-07-01
JPS4985098A (en) 1974-08-15
DE2347727C2 (en) 1986-12-11
DE2347727A1 (en) 1974-04-04
NL176458B (en) 1984-11-16
ZA737131B (en) 1974-08-28
BE805178A (en) 1974-03-21

Similar Documents

Publication Publication Date Title
SE407579B (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONOMETHYLGLICIN
NO140731C (en) PROCEDURE FOR THE PREPARATION OF DIMETHYLETER
SE382053B (en) PROCEDURE FOR THE PREPARATION OF BIFENYLYL ALKANOYLAMINOPYRIDINES
SU439983A3 (en) The method of obtaining derivatives of ethylenebenzoyl
RO71354A (en) PROCEDURE FOR THE PREPARATION OF P-HALOPHENYL-2-PYRROLIDINONE
SE399701B (en) PROCEDURE FOR THE PREPARATION OF HYDROXYALKYLDIAMINE
FI56687B (en) FOERFARANDE FOER FRAMSTAELLNING AV VINCAMIN- OCH APOVINCAMINSYRAESTRAR MED INVERKAN PAO BLODCIRKULATIONEN OCH BLODTRYCKET
SE383151B (en) PROCEDURE FOR THE PREPARATION OF 1-HYDROXY-2-PYRIDONES
FI54311C (en) PROCEDURE FOR THE FRAMSTATION OF AV PYRIMIDINOBENSO-OXAZEPINER -TIAZEPINER -DIAZEPINER OCH -AZEPINER WITH INVERKAN PAO CENTRALNERVSYSTEMET
SE394436B (en) PROCEDURE FOR THE PREPARATION OF 7-HALOGEN-LINCOMYCINES
SE380272B (en) PROCEDURE FOR THE PREPARATION OF N-PHOSPHONE METHYLLYCINE
SE393111B (en) PROCEDURE FOR THE PREPARATION OF D-2-HALOGEN-6-METHYL-8-SUBSTITUTED - ERGOLINE
SE385011B (en) PROCEDURE FOR THE PREPARATION OF ALFA-LINCOSAMINIDES
FI56830B (en) PROCEDURE FOR THE PREPARATION OF ASPARAGINYLGRUPPER INNEHAOLLANDE BIOLOGISKT AKTIVA POLYPEPTIDER
SE415355B (en) PROCEDURE FOR THE PREPARATION OF PHOSPHONOTIOUREIDS
SE393808B (en) PROCEDURE FOR THE PREPARATION OF ISOMALTITE
SE408418B (en) PROCEDURE FOR THE PREPARATION OF 5-FLUOR-PYRIMIDINES
SE391717B (en) PROCEDURE FOR THE PREPARATION OF 4-ARYL-5-AMINOALKYL-4-OXAZOLIN-2-ONERS
FI56670B (en) PROCEDURE FOR FRAMSTATION OF AV 5-CYCLOHEXYL-6-HALOGENINDAN-1-CARBOXYLSYRADERIVAT
AR197040A1 (en) PROCEDURE FOR THE PREPARATION OF NEW BIPHENYLACETAMIDES
SE380805B (en) PROCEDURE FOR THE PREPARATION OF OXAZOLES
SE389862B (en) PROCEDURE FOR THE PREPARATION OF ALFA-6-DEOXITETTRACYCLINES
SE380795B (en) PROCEDURE FOR THE PREPARATION OF THIOCARBAMIDS
SE382046B (en) PROCEDURE FOR THE PREPARATION OF 1-ARYLOXY-2-PROPANOL
AR205791A1 (en) PROCEDURE FOR THE PREPARATION OF SULFOBENZO LACTAMAS